Jason E. Stadanlick, Ph.D.
Affiliations: | 2008 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Immunology, Molecular Biology, Cell BiologyGoogle:
"Jason Stadanlick"Mean distance: 30533.1
Parents
Sign in to add mentor| Michael P. Cancro | grad student | 2008 | Penn | |
| (Tonic B cell antigen receptor signals supply an NF-kappa substrate, p100, for prosurvival BLyS signaling.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Quinn WJ, Jiao J, TeSlaa T, et al. (2020) Lactate Limits T Cell Proliferation via the NAD(H) Redox State. Cell Reports. 33: 108500 |
| Klampatsa A, O'Brien SM, Thompson JC, et al. (2019) Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes. Oncoimmunology. 8: e1638211 |
| Singhal S, Stadanlick J, Annunziata MJ, et al. (2019) Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer. Science Translational Medicine. 11 |
| Shilling D, Stadanlick JE, Meng W, et al. (2018) Oligoclonal Expansion of Cd8+ T Cells during Idiopathic Multicentric Castleman Disease Flares Suggests an Antigen Driven Process Blood. 132: 2411-2411 |
| Predina JD, Newton AD, Connolly C, et al. (2017) Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Akimova T, Zhang T, Negorev D, et al. (2017) Human lung tumor FOXP+ Tregs upregulate four "Treg-locking" transcription factors. Jci Insight. 2 |
| Solanki NR, Stadanlick JE, Zhang Y, et al. (2016) Rpl22 Loss Selectively Impairs αβ T Cell Development by Dysregulating Endoplasmic Reticulum Stress Signaling. Journal of Immunology (Baltimore, Md. : 1950) |
| Rao S, Cai KQ, Stadanlick JE, et al. (2016) Ribosomal protein Rpl22 controls the dissemination of T cell lymphoma. Cancer Research |
| Rao S, Cai K, Stadanlick J, et al. (2015) Novel Role for Rpl22 in Controlling Lymphoma Progression and Dissemination Blood. 126: 3669-3669 |
| Rao S, Stadanlick JE, Cai KQ, et al. (2015) Abstract A07: Loss of Rpl22 promotes tumor progression through regulation of angiogenesis and dissemination. Clinical Cancer Research. 21 |